Evidence map›Paper›PMID 40181000›Full record

ArticleScientific reports2025

Dementia classification using two-channel electroencephalography features.

Kuk-In Jang, Yeong In Kim, Hyo Jin Ju, Sang Joon An, Pyong Woon Park

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kuk-In JangCorporate Research Institute, Panaxtos Corp, Seoul, Republic of Korea.
Yeong In KimDepartment of Neurology, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Republic of Korea.
Hyo Jin JuThe Convergence Institute of Healthcare and Medical Science, Catholic Kwandong University College of Medicine, Incheon, Republic of Korea.
Sang Joon An *Department of Neurology, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Republic of Korea. neuroan@gmail.com.
Pyong Woon Park *Corporate Research Institute, Panaxtos Corp, Seoul, Republic of Korea. panipara@panaxtos.com.

Funding

R&D Program for Forest Science Technology 2022438C10-2222-0102R&D Program for Forest Science Technology FTIS 2021387D10-2323-0101
6 · The paper itself

Abstract

This study aimed to develop a novel classification model using wearable two-channel electroencephalography (EEG) data to differentiate between patients with dementia and normal controls (NCs). We employed an extreme gradient boosting (Xgboost) model combined with recursive feature elimination with cross-validation (RFECV) to classify patients and NCs. The study included 54 NCs and 29 patients with dementia. Resting-state EEG was recorded, and Mini-Mental Status Exam (MMSE) and Clinical Dementia Rating (CDR) assessments were conducted. Significant differences were observed in peak frequency (PF), alpha (A), theta (T), the ratio of alpha to theta (A/T), the ratio of alpha to low-beta (A/BL), and coherence (CH) between patients and NCs. Patients with dementia exhibited decreases in PF, CH_A/T, CH_A/BL, A/T, and A/BL, while an increase in T was noted. The primary finding was that the Xgboost model, a tree ensemble classification, achieved a balanced accuracy of 97.05% with the RFECV-selected feature, which was PF. This study suggests that the novel Xgboost with RFECV classification model using two-channel EEG data could be a valuable tool for diagnosing dementia.

Indexed as

DementiaElectroencephalographyAgedAged, 80 and overFemaleHumansMaleMiddle AgedClassificationDementiaMachine learningTwo-channel EEGXgboost

Identifiers

PMID40181000
PMCPMC11968806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.